Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

Voclosporin’s phase 2 test results chance of being wrong is less than .001%. Now, the same test protocol (phase3) is repeated with just more test subjects in places where health facilities are easily accessible to the patients. The test may have already ended or about to end. As we can see, there is no alarm bell ringing or
In other words, test is not being stopped for any reason at all. Then came this raid on the share price by you know who and the shares plummeted. We were expecting to hear news regarding the downturn but there was none. My guess is that in the next two weeks, if there is no news we should be seeing a steady rise of the share price before the release of the P3 results...just my opinion.